Login to Your Account

Other News To Note

Wednesday, May 30, 2012

• Ensemble Therapeutics Inc., of Cambridge, Mass., said it will begin a drug discovery collaboration with South San Francisco-based Genentech Inc., a member of the Roche Group, for macrocyclic drug targets using its Ensemblin collection of more than 5 million macrocycles.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription